SCHEMBL20150849

SCHEMBL20150849

COc1ccc(/C=N/O)c(F)c1F

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 7/20 0.42
LMNA P02545 4/20 0.42
KDM4E B2RXH2 3/20 0.42
HTT P42858 1/20 0.42
TSHR P16473 2/20 0.41
KMT2A Q03164 3/20 0.41
L3MBTL1 Q9Y468 2/20 0.41
ALDH1A1 P00352 6/20 0.40
MEN1 O00255 2/20 0.37
MAPT P10636 3/20 0.36
USP2 O75604 1/20 0.36
GAA P10253 1/20 0.36
CYP1A2 P05177 1/20 0.36
NPC1 O15118 1/20 0.35
NFKB1 P19838 1/20 0.35
RAB9A P51151 1/20 0.35
NFKB2 Q00653 1/20 0.35
RELA Q04206 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
TUBB1 Q9H4B7 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20148159 1.00 HPGD (0.42) HPGDLMNAKDM4EHTTTSHR
SCHEMBL20150808 0.84 KMT2A (0.44) HPGDLMNAKDM4EHTTTSHR
SCHEMBL20148160 0.84 KMT2A (0.44) HPGDLMNAKDM4EHTTTSHR
SCHEMBL9608 0.84 LMNA (0.53) HPGDLMNAKDM4EHTTTSHR
SCHEMBL13002981 0.84 LMNA (0.53) HPGDLMNAKDM4EHTTTSHR
SCHEMBL9609 0.84 LMNA (0.53) HPGDLMNAKDM4EHTTTSHR
SCHEMBL29792596 0.84 LMNA (0.53) HPGDLMNAKDM4EHTTTSHR
SCHEMBL17221495 0.79 KDM4E (0.56) HPGDLMNAKDM4EHTTKMT2A
SCHEMBL17221496 0.79 KDM4E (0.56) HPGDLMNAKDM4EHTTKMT2A
SCHEMBL27689860 0.76 LMNA (0.50) HPGDLMNAKDM4EHTTTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10370370-B2 Aminobenzisoxazole compounds as agonists of α7-nicotinic acetylcholine receptors AXOVANT SCIENCES GMBH (CH) 2019-08-06 US disclosed
US-20180134696-A1 Aminobenzisoxazole Compounds as Agonists of Alpha7-Nicotinic Acetylcholine Receptors FORUM PHARMACEUTICALS, INC. 2018-05-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10370370-B2 Aminobenzisoxazole compounds as agonists of α7-nicotinic acetylcholine receptors CHRNA7, CHRNA5, CHRNA2 HPGD 1919/4885LMNA 2396/4885KDM4E 2804/4885
US-20180134696-A1 Aminobenzisoxazole Compounds as Agonists of Alpha7-Nicotinic Acetylcholine Receptors CHRNA7, CHRNA5, CHRNA2 HPGD 1289/4885LMNA 2450/4885KDM4E 3741/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.